Humankind Investments’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-10,112
Closed -$307K – 72
2025
Q3
$307K Buy
10,112
+2,142
+27% +$64.9K 0.07% 109
2025
Q2
$250K Buy
7,970
+2,282
+40% +$75.5K 0.06% 125
2025
Q1
$217K Buy
5,688
+452
+9% +$19.2K 0.06% 133
2024
Q4
$230K Buy
5,236
+88
+2% +$3.87K 0.06% 132
2024
Q3
$222K Buy
+5,148
New +$229K 0.08% 128

Other funds holding ENOV

Humankind Investments's ENOV Position: Q4 2025 in Review

Humankind Investments sold out of Enovis (ENOV) in Q4 2025, closing a stake of 10,112 shares — an estimated $307K sold.

Humankind Investments first reported a position in ENOV in Q3 2024 and held it in 5 quarters. The position peaked at $307K in Q3 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

  • Humankind Investments reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 10,112 Enovis shares in Q4 2025, an estimated $307K.
  • Humankind Investments first reported a position in Enovis in Q3 2024 and held it in 5 quarters.
  • Humankind Investments's Enovis position peaked at $307K in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.